Xinranyicheng Medical Technology Group
Since its establishment in 2006, we have been dedicated to providing full-industry-chain services in the healthcare sector. Headquartered in Beijing with branch offices in Shenzhen, Chengdu, Tianjin, Shanghai, and Nanjing, we have built a nationwide strategic network.The group integrates two core divisions—Xinranyicheng Medical Consulting and Tianjin Sequoia Medical Technology—to deliver end-to-end "R&D-Production-Market Access" solutions for global clients.

Core Business Systems
Consulting Empowerment (Xinranyicheng):
As a pioneer in China's medical device regulatory consulting, we have assembled a professional team well-versed in domestic and international regulations, equipped with robust practical expertise. Specializing in risk assessment, opportunity mapping, and China market access services for enterprises across the Americas, Europe, and Asia-Pacific, we excel particularly in the dental equipment sector. To date, we have supported 300+ global companies in obtaining product registrations.

Intelligent Innovation (Tianjin Sequoia):
Leveraging our R&D and production base in Tianjin Economic-Technological Development Area, we focus on developing dental aesthetic restoration materials. Our vertically integrated ecosystem spans "technology innovation-smart manufacturing-clinical services." The product portfolio includes direct restorative resins, all-ceramic restoration systems, preventive dental materials, and personalized aesthetic solutions, offering precise treatment options for dentists, dental labs, and patients.

Global Service Network
Through coordinated operations between our Beijing headquarters, five regional hubs, and the Tianjin innovation hub, we have established a delivery system covering China's major economic zones. Our service network now reaches 30+ countries worldwide, assisting international brands in localizing operations while empowering domestic innovators to expand globally. In oral healthcare, our unique "Consulting + Product" dual-drive model has successfully helped partners reduce market access cycles by 40%.